Kexing Biopharm

Strong marketing capacity and early overseas layout 40+ fot marker access,60+ for registration,100+ for customer agency.

Strategy: Make Kexing Biopharm the most influential overseas professional commercial platform in the pharmaceutical field With high brand added-values

Area - Global Market

Layouts at an earlier time: Professional regulation team familiar with local regulations and markets

Layouts in a wide range of regions: Europe, Asia, America, and Africa

Key areas

Diseases: Oncology &immunological, and endocrine

Types:: monoclonal antibody drugs, bispecific antibody drugs, small molecule drugs, nucleic acid drugs, and polypeptide drugs

Partnership

Challenges: regulatory requirements, market changes, globalization, quality systems...

Capability: R&D of innovator drugs, production at high-quality/high-standard, cost advantages - exploring the global market

Mode

Comprehensive Commercial Cooperation

Market analysis, registration, clinical studies, sales and audi

10+ years of long-term cooperation at a trade price

Cooperation for products, industrial strategy, and industrialization

Marketing Features

Focus on global emerging markets for a long period of time

Southeast Asia, South America, North Africa, Russia...

Pass the review of all GMP-related documents with approved applications for market access in many countries